SCHEMBL8725920

SCHEMBL8725920

NNOC(=O)CCC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PHF8 Q9UPP1 6/20 0.48
KDM2A Q9Y2K7 6/20 0.48
KDM5C P41229 5/20 0.48
KDM4E B2RXH2 4/20 0.48
EGLN1 Q9GZT9 6/20 0.45
LMNA P02545 6/20 0.45
ALKBH5 Q6P6C2 1/20 0.45
SUCNR1 Q9BXA5 1/20 0.45
KDM6B O15054 3/20 0.43
TSHR P16473 4/20 0.39
GABRR1 P24046 2/20 0.39
FOLH1 Q04609 1/20 0.39
SLC15A2 Q16348 1/20 0.36
MAPK1 P28482 1/20 0.36
SLC13A3 Q8WWT9 1/20 0.36
OR51E2 Q9H255 1/20 0.36
SLC22A6 Q4U2R8 1/20 0.35
GABRR3 A8MPY1 1/20 0.35
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1401476 0.89 TSHR (0.45) PHF8KDM2AKDM5CKDM4ELMNA
SCHEMBL29661912 0.79 EGLN1 (0.50) PHF8KDM2AKDM5CKDM4EEGLN1
SCHEMBL1361646 0.79 TSHR (0.43) LMNATSHRHDAC3CYP1A2HDAC1
SCHEMBL29023627 0.78 EGLN1 (0.43) PHF8KDM2AKDM5CKDM4EEGLN1
SCHEMBL28714993 0.77 EGLN1 (0.47) PHF8KDM2AKDM5CKDM4EEGLN1
SCHEMBL8186238 0.76 EGLN1 (0.41) PHF8KDM2AKDM5CKDM4EEGLN1
SCHEMBL9345726 0.76 EGLN1 (0.41) PHF8KDM2AKDM5CKDM4EEGLN1
SCHEMBL4316216 0.75 MGAM (0.36) LMNATSHRCYP1A2NFKB1
SCHEMBL712108 0.75
SCHEMBL246949 0.75 PHF8 (0.48) PHF8KDM2AKDM5CKDM4EEGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110636841-A Pharmaceutical composition for preventing and treating cancer comprising malic acid-aspartic acid shuttle inhibitor and anticancer agent as active ingredients 国立癌症研究中心 2019-12-31 CN claimed
US-5756824-A Process for the preparation of carbazates BAYER AKTIENGESELLSCHAFT (DE) 1998-05-26 US disclosed